The FDA cleared the investigational new drug application of IDE849, a potential first-in-class DLL3-targeted antibody-drug ...

The table below is a review of notable updates that occurred in April 2025 for investigational products in development.

With a nickname, logos and everything that goes with a permanent brand identity now officially a part of who they are, the ...

Rad Power's Mother's Day sale takes up to $500 off e-bikes with kid-safe bundles on the RadWagon Cargo e-bikes, EcoFlow phase 2 sale, more ...

The Winnipeg Jets host the Dallas Stars in Game 2 of their second round Stanley Cup Playoffs series on Friday, May 9.

The NHL team in Salt Lake City is now known as the Utah Mammoth. Owners Ryan and Ashley Smith unveiled the franchise’s ...

The NHL team in Salt Lake City is now known as the Utah Mammoth. Owners Ryan and Ashley Smith unveiled the franchise’s ...

Compass Pathways PLC (CMPS) advances in treatment-resistant depression trials while maintaining a robust financial position.

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Phase 3 results Tarlatamab (Amgen) Bispecific delta-like ligand 3-directed CD3 T-cell engager Treatment of small cell lung cancer in patients who progressed on or after a single line of platinum ...

SolarEdge's new solar-powered EV charger helps businesses cut fleet charging costs by up to 70%, and it's available now.